Correlation Between Thorne HealthTech and Integrated Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Thorne HealthTech and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Thorne HealthTech and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Thorne HealthTech and Integrated Biopharma, you can compare the effects of market volatilities on Thorne HealthTech and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Thorne HealthTech with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Thorne HealthTech and Integrated Biopharma.

Diversification Opportunities for Thorne HealthTech and Integrated Biopharma

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Thorne and Integrated is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Thorne HealthTech and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Thorne HealthTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Thorne HealthTech are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Thorne HealthTech i.e., Thorne HealthTech and Integrated Biopharma go up and down completely randomly.

Pair Corralation between Thorne HealthTech and Integrated Biopharma

If you would invest  33.00  in Integrated Biopharma on August 26, 2024 and sell it today you would earn a total of  0.00  from holding Integrated Biopharma or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Thorne HealthTech  vs.  Integrated Biopharma

 Performance 
       Timeline  
Thorne HealthTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Thorne HealthTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Thorne HealthTech is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Integrated Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Thorne HealthTech and Integrated Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Thorne HealthTech and Integrated Biopharma

The main advantage of trading using opposite Thorne HealthTech and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Thorne HealthTech position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.
The idea behind Thorne HealthTech and Integrated Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities